Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong
· Delayed Price · Currency is HKD
102.50
+0.50 (0.49%)
Last updated: Mar 10, 2026, 11:59 AM HKT
Vigonvita Life Sciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -211.4 | 12.09 |
| Depreciation & Amortization | 32.85 | 16.82 |
| Other Amortization | 0.77 | 0.02 |
| Loss (Gain) From Sale of Assets | 0.04 | - |
| Loss (Gain) From Sale of Investments | -0.22 | - |
| Stock-Based Compensation | 14.75 | 14.75 |
| Provision & Write-off of Bad Debts | 2.79 | 2.4 |
| Other Operating Activities | 9.84 | 1.29 |
| Change in Accounts Receivable | 25.85 | -28.05 |
| Change in Inventory | -0.08 | -2.11 |
| Change in Accounts Payable | 8.7 | 16.7 |
| Change in Unearned Revenue | -1.41 | 5.53 |
| Change in Other Net Operating Assets | 8.68 | -8.77 |
| Operating Cash Flow | -108.85 | 30.67 |
| Capital Expenditures | -77.68 | -86.72 |
| Sale (Purchase) of Intangibles | -10.47 | -26.13 |
| Investment in Securities | 0.22 | - |
| Other Investing Activities | -0.48 | -48.02 |
| Investing Cash Flow | -88.41 | -160.87 |
| Long-Term Debt Issued | 263.18 | 172.35 |
| Long-Term Debt Repaid | -178.86 | -84.05 |
| Net Debt Issued (Repaid) | 84.32 | 88.3 |
| Issuance of Common Stock | 160 | - |
| Other Financing Activities | -22.14 | -11.8 |
| Financing Cash Flow | 222.18 | 76.5 |
| Foreign Exchange Rate Adjustments | 0.24 | 0.25 |
| Net Cash Flow | 25.16 | -53.46 |
| Free Cash Flow | -186.53 | -56.05 |
| Free Cash Flow Margin | -1576.46% | -28.07% |
| Free Cash Flow Per Share | -1.28 | -0.39 |
| Cash Interest Paid | 14.79 | 11.8 |
| Levered Free Cash Flow | -130.2 | - |
| Unlevered Free Cash Flow | -120.1 | - |
| Change in Working Capital | 41.74 | -16.7 |
Source: S&P Capital IQ. Standard template.
Financial Sources.